Harte Hanks Q2 Revenue Down 14.2%, Company Extends Line of Credit with Texas Capital Bank.
PorAinvest
jueves, 7 de agosto de 2025, 4:52 pm ET1 min de lectura
HHS--
The company attributed the revenue decline to pricing pressure, volume reductions, and timing fluctuations. Harte Hanks also announced executive changes, including the appointment of Sharona Sankar-King as Chief Customer and Data Officer. Additionally, the company has been expanding its services by acquiring an exclusive license to ADS Data Direct's medical ailment database and partnering with Outreach to provide sales solutions. The strategic focus on "Project Elevate" for operational efficiencies and cost control appears necessary given the revenue declines, with restructuring charges of $0.1 million tied to this initiative [1].
The company's cash position improved by late July, with a cash balance of $9.9 million, indicating that cost-cutting measures may be bearing fruit. Despite the challenging revenue environment, Harte Hanks maintained positive EBITDA and a healthy balance sheet, providing a strong foundation for future growth and innovation. The company continues to execute on its long-term value strategy, focusing on operational efficiencies, new customer acquisition, and cost controls to support sustainable profitability [1].
References:
[1] https://www.stocktitan.net/news/HHS/harte-hanks-reports-second-quarter-2025-2yswim7sw36p.html
Harte Hanks, a marketing services provider, reported a 14.2% decline in Q2 revenue to $45M, missing street estimates of $47.5M. The company also announced executive changes, including the appointment of Sharona Sankar-King as Chief Customer and Data Officer. Harte Hanks has been expanding its services, including acquiring an exclusive license to ADS Data Direct's medical ailment database and partnering with Outreach to provide sales solutions.
Harte Hanks (NASDAQ:HHS), a leading global customer experience company, reported its second-quarter 2025 financial results, reflecting mixed performance with operational discipline despite revenue challenges. The company reported total revenue of $38.6 million, a decline of 14.2% compared to Q2 2024. The net loss was $0.3 million ($0.05 per share), while EBITDA stood at $1.1 million. Revenue declines were observed across all divisions: Customer Care revenue fell 4.4% to $11.8 million, Fulfillment & Logistics Services dropped 11.6% to $18.1 million, and Marketing Services decreased 28.7% to $8.7 million. Despite these declines, Harte Hanks maintained a strong financial position with $4.8 million in cash, no debt, and $24.0 million available credit capacity [1].The company attributed the revenue decline to pricing pressure, volume reductions, and timing fluctuations. Harte Hanks also announced executive changes, including the appointment of Sharona Sankar-King as Chief Customer and Data Officer. Additionally, the company has been expanding its services by acquiring an exclusive license to ADS Data Direct's medical ailment database and partnering with Outreach to provide sales solutions. The strategic focus on "Project Elevate" for operational efficiencies and cost control appears necessary given the revenue declines, with restructuring charges of $0.1 million tied to this initiative [1].
The company's cash position improved by late July, with a cash balance of $9.9 million, indicating that cost-cutting measures may be bearing fruit. Despite the challenging revenue environment, Harte Hanks maintained positive EBITDA and a healthy balance sheet, providing a strong foundation for future growth and innovation. The company continues to execute on its long-term value strategy, focusing on operational efficiencies, new customer acquisition, and cost controls to support sustainable profitability [1].
References:
[1] https://www.stocktitan.net/news/HHS/harte-hanks-reports-second-quarter-2025-2yswim7sw36p.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios